Penile Vibratory Stimulation in the Prevention of Sexual Dysfunction and Urinary Incontinence After Radical Prostatectomy
Planned Penile Vibratory Stimulation in the Prevention of Sexual Dysfunction and Urinary Incontinence After Radical Prostatectomy: a Randomized Controlled Study
1 other identifier
interventional
100
1 country
1
Brief Summary
To investigate if post-operative penile vibration stimulation kan be used to reduce or prevent sexual dysfunction and urinary incontinence after radical prostatectomy. This will be done in a randomized, controlled, non-blinded study. Men that undergo nerve preserving surgery for prostate cancer is allocated into an intervention group and a control group. A total of 100 men will be included for a power of 80%. The intervention group will be instructed to use the "Ferticare 2.0" vibrator for at least five minutes a day with an amplitude of 1 mm and frequency of 90 Hz (these settings were found in a pilot study) for a total of 9 months. Both groups will do the standard pelvic floor training program and both groups will be offered regular phosphodiesterase-5-inhibitor treatment. Before surgery, 3, 6 and 10 months after the patients will have to fill out four different questionnaires regarding sexual and urinary function, including IIEF-EF, EHS, "neglected side effects" and ICIQ-SF. (10 months is due to a wash-out period of 1 month after the intervention). The collected data will be analysed and the primary goal is to see if there is a significant difference in average spontaneous IIEF-EF score in the two groups 10 months after the surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2023
CompletedFirst Posted
Study publicly available on registry
January 11, 2024
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedMarch 12, 2024
March 1, 2024
2.1 years
December 29, 2023
March 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Erectile function
The erectile function compared to controls measured by IIEF-EF
10 months
Secondary Outcomes (6)
ICIQ-UI-SF: The International Consultation on Incontinence Questionnaire - Urinary Incontinence - short form
10 months
IIEF-EF score (The International Index of Erectile Function - Erectile Function)
10 months
Diaper weighing test
10 months
IIEF-EF (The International Index of Erectile Function - Erectile Function) over 25
10 months
EHS (Erection Hardness Scale)
10 months
- +1 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALThe group randomized to use the vibrator for 9 months
Controls
NO INTERVENTIONUsual standard treatment
Interventions
In addition to standard treatment with PDE5-inhibitors the intervention is daily stimulation for five minutes with the vibrator for 9 months
Eligibility Criteria
You may qualify if:
- Men who are undergoing nerve-sparing radical prostatectomy
- Pre operative erectile function of IIEF-EF \> 25
- Sexually active . Continent before surgery defined as a score of 0 on the ICIQ-SF questionnaire
You may not qualify if:
- Urinary incontinent before surgery
- Comorbidity that prevents the patient from taking PDE5-inhibitors
- Disease in the penis or in the penile skin (Peyronies, phimosis)
- Problems using the vibrator ie impaired function of the hands
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Herlev and Gentofte Hospital
Herlev, 2730, Denmark
Study Officials
- PRINCIPAL INVESTIGATOR
Mikkel Fode, MD, PhD
Department of Urology, Herlev and Gentofte University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD fellow
Study Record Dates
First Submitted
December 29, 2023
First Posted
January 11, 2024
Study Start
February 1, 2024
Primary Completion
March 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
March 12, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
Available upon request. Subject to approval from the Danish Data Protection Agency.